Taken together, these results suggest that TFF1 acts as a tumor suppressor during L1-mediated tumorigenesis and that its downregulation in CRC cells is a necessary step for tumor progression conferred by L1. The gene discussed is TFF1; the disease is colorectal carcinoma.